AbCellera Biologics Inc. (ABCL) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $128.51M | -17.8% |
| 2024 | $156.32M | +17.3% |
| 2023 | $133.32M | -65.5% |
| 2022 | $386.54M | -18.8% |
| 2021 | $476.14M | -19.9% |
| 2020 | $594.12M | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $128.51M | -17.8% |
| 2024 | $156.32M | +17.3% |
| 2023 | $133.32M | -65.5% |
| 2022 | $386.54M | -18.8% |
| 2021 | $476.14M | -19.9% |
| 2020 | $594.12M | — |